As a result, the expressions of SERPINE1 were significantly increased in the other two types of cancer cell lines when treated with each of the three purinergic antiplatelet agents compared to the control and aspirin-treated cell lines (Figure 4B). This evidence concerns the gene SERPINE1 and cancer.